Who Exports Esomeprazole from India — 643 Suppliers Behind a $456.5M Market
India's esomeprazole export market is supplied by 643 active exporters who collectively shipped $456.5M across 9,532 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 43.4% market share, followed by CIPLA LIMITED and MYLAN LABORATORIES LIMITED. The top 5 suppliers together control 77.1% of total export value, reflecting a concentrated market structure.
Top Esomeprazole Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading esomeprazole exporter from India, holding a 43.4% share of the $456.5M market across 9,532 shipments from 643 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, MYLAN LABORATORIES LIMITED, MICRO LABS LIMITED, DR.REDDY'S LABORATORIES LTD — collectively control 77.1% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (43.4%), CIPLA LIMITED (15.1%), MYLAN LABORATORIES LIMITED (7.7%), MICRO LABS LIMITED (6.7%), DR.REDDY'S LABORATORIES LTD (4.1%).
Top Esomeprazole Exporters from India
Ranked by export value · 643 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTSOMEXWELL-40ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS] | $198.0M | 19 | 43.4% |
| 2 | CIPLA LIMITED ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEAHELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $69.2M | 15 | 15.1% |
| 3 | MYLAN LABORATORIES LIMITED ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $35.3M | 6 | 7.7% |
| 4 | MICRO LABS LIMITED SOMEXWELL-40ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]HELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $30.6M | 19 | 6.7% |
| 5 | DR.REDDY'S LABORATORIES LTD ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEAESOMEPRAZOLE TABLETS 40MG (ESOMEPRAZOL RESOMEPRAZOLE CAPSULE | $18.7M | 5 | 4.1% |
| 6 | TORRENT PHARMACEUTICALS LTD SOMEXWELL-40ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $9.8M | 22 | 2.2% |
| 7 | BIOCON PHARMA LIMITED ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $9.4M | 1 | 2.1% |
| 8 | HETERO LABS LIMITED SOMEXWELL-40ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]HELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $9.0M | 13 | 2.0% |
| 9 | ANNORA PHARMA PRIVATE LIMITED ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $5.7M | 1 | 1.2% |
| 10 | JUBILANT GENERICS LIMITED ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTNEXIPRAZ IV 40MG/VIAL (ESOMEPRAZOLE SODIESOMEPRAZOLE TABLETS 40MG (ESOMEPRAZOL R | $5.2M | 10 | 1.1% |
| 11 | DR REDDYS LABORATORIES LIMITED SOMEXWELL-40ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $4.8M | 2 | 1.0% |
| 12 | ZYDUS LIFESCIENCES LIMITED ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $4.0M | 3 | 0.9% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LTD ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTSOMEXWELL-40ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS] | $3.4M | 8 | 0.7% |
| 14 | PELL TECH HEALTH CARE PRIVATE LIMITED ESOMEPRAZOLE TABLETS 40MG (ESOMEPRAZOL RESOMEPRAZOLE CAPSULEESOMEPRAZOL ESOMEPRAZOLE CAPSULE | $3.0M | 5 | 0.7% |
| 15 | INNOVA CAPTAB LIMITED ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]HELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMYESOMAC 40 MG TABLETS (ESOMEPRAZOLE 40MG | $3.0M | 2 | 0.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Esomeprazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | 9 | Sun Pharma has received FDA approvals and holds WHO-GMP and EU GMP certification |
| Cipla Limited | Approved | Yes | Yes | 7 | Cipla has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Mylan Laboratories Limited | Approved | Yes | Yes | 11 | Mylan has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Micro Labs Limited | Approved | Yes | Yes | 2 | Micro Labs has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Dr. Reddy's Laboratories Ltd. | Approved | Yes | Yes | 2 | Dr. Reddy's has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Torrent Pharmaceuticals Ltd. | Approved | Yes | Yes | 2 | Torrent has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Biocon Pharma Limited | Approved | Yes | Yes | 1 | Biocon has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Hetero Labs Limited | Approved | Yes | Yes | 4 | Hetero has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Jubilant Generics Limited | Approved | Yes | Yes | Not specified | Jubilant has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| Zydus Lifesciences Limited | Approved | Yes | Yes | 8 | Zydus has FDA approvals and holds WHO-GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 10 leading Esomeprazole exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Esomeprazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often dubbed the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts major pharmaceutical companies like Laurus Labs and Granules India, which specialize in APIs and generic formulations. Laurus Labs focuses on APIs, generic formulations, and custom synthesis, while Granules India is involved in the manufacture and sale of APIs, pharmaceutical formulation intermediates, and finished dosage forms. This concentration of API manufacturers makes Hyderabad a critical node in the supply chain for drugs like Esomeprazole.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical formulations industry. Companies such as Sun Pharmaceutical Industries Limited, headquartered in Mumbai but with significant operations in Gujarat, play a substantial role in this region. Sun Pharma, India's largest pharmaceutical company and the fourth-largest specialty generic pharmaceutical company globally, reported revenues of $198.0 million from Esomeprazole exports, accounting for 43.4% of India's total Esomeprazole exports. The region's advanced infrastructure and investor-friendly policies have fostered a thriving environment for pharmaceutical formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. Mumbai, being the financial capital, provides strategic advantages for companies like Sun Pharma, which has its headquarters in the city. The region's proximity to major ports facilitates efficient export logistics, contributing to India's substantial pharmaceutical exports. In the case of Esomeprazole, the United States (24.4%), Canada (19.6%), and Belgium (16.4%) are among the top destinations, underscoring the region's role in global distribution.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. Companies like Unichem Laboratories have established manufacturing facilities in Baddi, leveraging these benefits to produce a range of pharmaceutical formulations. This region's growth underscores the impact of policy incentives on the pharmaceutical industry's expansion.
5Sourcing Recommendations
- Diversify Supplier Base: While Sun Pharma is a dominant exporter of Esomeprazole, consider engaging with other significant suppliers like Cipla Limited and Dr. Reddy's Laboratories Ltd to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad's API manufacturing capabilities for raw material sourcing and Ahmedabad-Vadodara's expertise in formulations for finished products to optimize the supply chain.
- Optimize Export Logistics: Capitalize on the Mumbai-Thane-Raigad region's proximity to major ports to streamline export processes and reduce lead times.
- Monitor Regulatory Compliance: Ensure all suppliers adhere to international regulatory standards, such as those set by the USFDA and EMA, to maintain product quality and facilitate market access.
By strategically engaging with these pharmaceutical clusters and adhering to these recommendations, companies can enhance their sourcing strategies for Esomeprazole, ensuring a robust and efficient supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Esomeprazole exporters from India
Dr. Reddy's Laboratories Ltd. — Dr. Reddy's explores joint bid for Cipla with Bain Capital
In September 2023, Dr. Reddy's Laboratories Ltd. was approached by Bain Capital to consider a joint bid to acquire a controlling stake in Cipla Ltd. Discussions were initiated to evaluate the feasibility of this acquisition. IMPACT: If successful, this acquisition could significantly enhance Dr. Reddy's market share in Esomeprazole exports.
Impact: If successful, this acquisition could significantly enhance Dr. Reddy's market share in Esomeprazole exports.
Sun Pharmaceutical Industries Ltd. — USFDA scrutiny delays generic drug approvals for Sun Pharma
In July 2024, Sun Pharmaceutical Industries Ltd. faced intensified scrutiny from the US Food and Drug Administration (USFDA), leading to delays in the approval of new generic drugs. This regulatory oversight affected the company's ability to introduce new products to the market. IMPACT: The delay in approvals may impact Sun Pharma's Esomeprazole export volumes to the United States.
Impact: The delay in approvals may impact Sun Pharma's Esomeprazole export volumes to the United States.
Dr. Reddy's Laboratories Ltd. — Dr. Reddy's expands CDMO services in India
In December 2025, Dr. Reddy's Laboratories Ltd. announced the expansion of its Contract Development and Manufacturing Organization (CDMO) services in India. This strategic move aims to leverage India's cost-effective capabilities to meet the growing global demand for pharmaceutical manufacturing. IMPACT: The expansion is expected to bolster Dr. Reddy's capacity for Esomeprazole production, potentially increasing export volumes.
Impact: The expansion is expected to bolster Dr. Reddy's capacity for Esomeprazole production, potentially increasing export volumes.
Common Questions — Esomeprazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which esomeprazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 1,649 recorded shipments worth $198.0M. CIPLA LIMITED (611 shipments) and MYLAN LABORATORIES LIMITED (179 shipments) are also established high-volume exporters.
Q How many esomeprazole manufacturers are there in India?
India has 643 active esomeprazole exporters with a combined export market of $456.5M across 9,532 shipments to 147 countries. The top 5 suppliers hold 77.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for esomeprazole from India?
Average FOB unit price: $4.31 per unit, ranging from $0.00 to $1467.29. Average shipment value: $47.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 643 verified Indian exporters of Esomeprazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 9,532 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 147 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9,532 Verified Shipments
643 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists